Nurix Therapeutics (NASDAQ:NRIX) PT Raised to $27.00
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective boosted by stock analysts at Royal Bank of Canada from $26.00 to $27.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price indicates a potential upside […]
More Stories
Major Automakers Side With Trump in Legal Battle Over Eased Fuel Economy Standards
By Kimberly Hayek A major auto industry group has thrown its support behind the Trump administration in a lawsuit brought...
Oil Prices Rise After Reports of Explosions on Iran’s Qeshm Island
By Evgenia Filimianova Oil prices climbed by more than 1.5 percent early on Nov. 3 after reports of explosions on...
Spanish Police Launch Investigation Into Death of Soccer Player After On-field Incident
By Elma Aksalic Spanish authorities have launched an investigation following the death of professional soccer player Jesús de Miguel, who...
Trump Designates Anti-Communism Week in Election Day Proclamation
By Travis Gillmore WASHINGTON—President Donald Trump declared Nov. 1 through Nov. 7 as Anti-Communism Week with a presidential action signed...
Trump Declares Outer Space Open for All Humans to Explore
By Jill McLaughlin President Donald Trump signed a proclamation Nov. 3 declaring the solar system and outer space to be...
2026 Midterms: 5 Takeaways
By Lawrence Wilson, Jeremy Lott and Jackson Richman Democrats won a sweeping victory on Nov. 3, taking control of both...